CoChat

A Genomic Signature of Influenza Infection Shows Potential for Presymptomatic Detection, Guiding Early Therapy, and Monitoring Clinical Responses

Open access

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Early, presymptomatic intervention with oseltamivir (corresponding to the onset of a published host-based genomic signature of influenza infection) resulted in decreased overall influenza symptoms (aggregate symptom scores of 23.5 vs 46.3), more rapid resolution of clinical disease (20 hours earlier), reduced viral shedding (total median tissue culture infectious dose [TCID50] 7.4 vs 9.7), and significantly reduced expression of several inflammatory cytokines (interferon-γ, tumor necrosis factor-α, interleukin-6, and others). The host genomic response to influenza infection is robust and may provide the means for early detection, more timely therapeutic interventions, a meaningful reduction in clinical disease, and an effective molecular means to track response to therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ofid/ofw007

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Response to influenza challenge followed by Early (red) and Standard (blue) Treatment (TX) with oseltamivir as measured by clinical symptoms (A) and viral shedding (B). Individual subject results (*, ◊) and mean values (lines) are shown. Time of administration of oseltamivir in the 2 groups is marked by vertical dotted gray lines. Early abrogation of the influenza genomic signature over time in subjects after Early treatment (red) and Standard treatment (blue) is similarly shown in panel (C). A heatmap demonstrates genomic signature score over time after inoculation in all subjects involved in the study (D). Subjects who received Early Treatment are marked with an (−).
Figure 1. Response to influenza challenge followed by Early (red) and Standard (blue) Treatment (TX) with oseltamivir as measured by clinical symptoms (A) and viral shedding (B). Individual subject results (*, ◊) and mean values (lines) are shown. Time of administration of oseltamivir in the 2 groups is marked by vertical dotted gray lines. Early abrogation of the influenza genomic signature over time in subjects after Early treatment (red) and Standard treatment (blue) is similarly shown in panel (C). A heatmap demonstrates genomic signature score over time after inoculation in all subjects involved in the study (D). Subjects who received Early Treatment are marked with an (−).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 28

Metadata

Authors
McClain, M. T., Nicholson, B. P., Park, L. P., Liu, T.-Y., Hero, A. O., Tsalik, E. L., Zaas, A. K., Veldman, T., Hudson, L. L., Lambkin-Williams, R., Gilbert, A., Burke, T., Nichols, M., Ginsburg, G. S., & Woods, C. W.
Affiliations
  • Duke University (US)
  • Veterans Health Administration (US)
  • National Center for Genome Resources (US)
  • University of Michigan (US)
  • hVIVO, London, United Kingdom
  • hVIVO (United Kingdom) (GB)
Corresponding author
McClain, Micah T.
Venue
Open Forum Infectious Diseases
Published
2016-01-01
Volume
3
Issue
1
Pages
ofw007-ofw007
ISSN
2328-8957 (ISSN-L)
OpenAlex
W2256139303
Cited by
28
References
15
Citations by year
2026: 1 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 6 · 2018: 6 · 2017: 3 · 2016: 2
FWCI
5.30
Type
journal article
Language
en
Open access
Locations
  • Open Forum Infectious Diseases (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • Veteran's Affairs Medical Center (1IK2CX000611)
  • Defense Advanced Research Projects Agency (lN66001-07-C-0092)
Topics
  • Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
  • Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Keywords
influenza, presymptomatic detection, oseltamivir, antiviral therapy, viral shedding, inflammatory cytokines, interferon-gamma, TNF-α, interleukin-6, host immune response

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.